Drug Information

Drug General Information
Drug ID
D0D3QE
Former ID
DNC006223
Drug Name
4-(2-pyrrolidin-1-yl-pentanoyl)benzonitrile
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528036]
Formula
C16H20N2O
Canonical SMILES
CCCC(C(=O)C1=CC=C(C=C1)C#N)N2CCCC2
InChI
1S/C16H20N2O/c1-2-5-15(18-10-3-4-11-18)16(19)14-8-6-13(12-17)7-9-14/h6-9,15H,2-5,10-11H2,1H3
InChIKey
AQQRGNNYEPRIIF-UHFFFAOYSA-N
PubChem Compound ID
11550626
Target and Pathway
Target(s) Sodium-dependent dopamine transporter Target Info Inhibitor [528036]
KEGG Pathway Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholism
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
Parkinson disease
Dopamine receptor mediated signaling pathway
Pathway Interaction Database Alpha-synuclein signaling
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Dopaminergic Neurogenesis
Parkinsons Disease Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Neurotransmitter Clearance In The Synaptic Cleft
References
Ref 528036J Med Chem. 2006 Feb 23;49(4):1420-32.1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
Ref 528036J Med Chem. 2006 Feb 23;49(4):1420-32.1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.